Precision medicine for Alzheimer's disease using patented DNA nanotechnology
Drugs are prescribed based on patient history, toxicology and on a trial and error basis. Esya’s platform enables quantitative measurement of individual response to drugs for personalised medicine.
A 360-Degree Perspective for Alzheimer's Disease based on Esya's patented DNA nanotechnology, unique biomarkers, and our multiomics platform
WHAT WE DO
A Paradigm Shift In How Alzheimer's Disease Manifests Opens Up A Whole New Way Of Diagnosing, Treating, And Managing The Disease
Standalone Diagnostic
For Early-Stage Alzheimer's Disease
Precision Medicine
Personalized Treatment Plans
Measurement & Monitoring
Disease Progression
If you crave challenges, there's no better place to be
Esya is a dynamic company operating at the intersection of biochemistry, technology and medicine. If you crave challenges and the chance to see your work impact the millions of lives touched by Alzheimer’s disease, there’s no better place to be.